Oasmia grants Medison exclusive marketing rights to Paclical micellular paclitaxel in Turkey and Israel

Oasmia Pharmaceutical AB

Sweden / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Medison Pharma Ltd.

Israel / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced